Effect of Bright Light Treatment On Elders In a Long Term Care Environment
NCT ID: NCT01042587
Last Updated: 2010-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2010-03-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. improve sleep quality
2. improve cognitive scores
3. improve depression scores
4. improve quality of life scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity Light Therapy in Alzheimer's Disease
NCT00065689
Bright Light Therapy for Individuals With Dementia
NCT02800850
Light Sensitization Study
NCT01327040
The Circadian Rhythm of ICU Patients With Acute Myocardial Infraction and the Effect of Light Therapy
NCT04953767
Bright Light Therapy in Older Adults With Moderate to Very Severe Dementia
NCT04949984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bright light
Bright light has been shown to entrain circadian rhythm so our treatment arm will use thirty minutes of early morning exposure to bright blue light for a four week period.
exposure to bright light
Elders will be engaged in an activity period which will focus their attention in the direction of bright light, thus ensuring viewing the light source for a daily exposure of thirty minutes.
red light
Low level red light is a weak entrainment stimulus of circadian rhythm. Elders in the control group will be exposed to low level red light as a placebo for thirty minutes daily for four weeks.
low luminosity red light
Low level red light should not entrain circadian rhythm and will serve as a placebo control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exposure to bright light
Elders will be engaged in an activity period which will focus their attention in the direction of bright light, thus ensuring viewing the light source for a daily exposure of thirty minutes.
low luminosity red light
Low level red light should not entrain circadian rhythm and will serve as a placebo control
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to give informed consent and complete the neuropsychological tests
Exclusion Criteria
* severe illness expected to preclude the ability to complete treatment
* moderate to severe dementia that precludes the ability to complete testing
* light sensitivity making treatment to light therapy uncomfortable
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Milton S. Hershey Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Penn State Milton S. Hershey Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noel H Ballentine, MD
Role: PRINCIPAL_INVESTIGATOR
Milton S. Hershey Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Masonic Villages
Elizabethtown, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32704
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.